iSage Rx (by Amalgam Rx)

by Amalgam Rx, Inc.  · Based in United States →Reimagining digital health with Medical-Grade AI™
Endocrinology Family Medicine Internal Medicine

Not available publicly; pursues insurance coverage model.
Regulatory Status Disclosed

Overview

iSage Rx by Amalgam Rx, Inc. is a prescription-only mobile application designed to assist adult patients with Type 2 diabetes and their healthcare providers in managing basal insulin titration.

The tool is intended for use in non-acute care settings and is specifically for patients with Type 2 diabetes who do not use mealtime insulin or an insulin pump.

iSage Rx integrates into a clinical workflow by allowing physicians to select from various clinically validated basal insulin algorithms, which can then be tailored to individual patient needs. Patients use the app to input their fasting blood glucose levels, and the app provides recommended basal insulin doses according to the prescribed titration plan. Healthcare providers can monitor patient progress, including starting doses and blood sugar levels, through a provider portal.

Notable capabilities include its FDA 510(k) clearance in the United States, and CE Mark in Europe, for automated titration of all major brands of basal insulin. The app also offers behavioral, clinical, and educational support for patients, such as supportive messages, video content on insulin administration, and information on what to expect during insulin therapy. iSage Rx has the capability to titrate basal insulin and medications that combine basal insulin and GLP-1 receptor agonists. It can connect with Bluetooth-enabled blood glucose meters for data collection.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated basal insulin titration for Type 2 diabetes
  • Clinically validated algorithms adaptable by physicians
  • Behavioral, clinical, and educational support for patients
  • Reminders for fasting blood glucose checks
  • Remote data monitoring by healthcare providers
  • Compatibility with major basal insulins (Lantus, Levemir, Toujeo, Tresiba, Basaglar)
  • Connectivity to Bluetooth-enabled blood glucose meters (Roche, Lifescan, Ascensia)
  • EHR integration for streamlined workflow and data return
  • Personalized dose recommendations based on daily fasting blood glucose
  • Supportive messages and video content for insulin administration

Use Cases

  • Automating basal insulin titration for Type 2 diabetes patients
  • Supporting patient self-management of insulin therapy
  • Enhancing glucose control in Type 2 diabetes patients
  • Providing educational and behavioral support for insulin users
  • Streamlining insulin dose optimization for healthcare providers
  • Integrating digital health solutions into EHR workflows

What Physicians Need to Know

Key Capabilities
Automated basal insulin titration for adults with Type 2 diabetes, supporting all major basal insulins (Lantus, Levemir, Toujeo, Tresiba, Basaglar). Provides personalized insulin dose recommendations based on daily fasting blood glucose input. Includes behavioral, clinical, and educational support (reminders, videos, trivia, educational messages) to aid patient self-management and adherence. Offers remote data monitoring capabilities for healthcare providers. Can also titrate medications combining basal insulin and GLP-1 receptor agonists.
Clinical Utility
Helps patients safely reach fasting blood glucose targets and achieve an optimal maintenance dose of insulin, potentially reducing hypoglycemia. Facilitates adherence to prescribed insulin dosing algorithms, addressing the issue of patients being unaware of or inadequately following titration requirements. Reduces the need for frequent in-office visits or phone consultations for insulin dose adjustments. Improves glucose levels and can lead to significant reductions in A1C.
Integration Options
Connects with Bluetooth-enabled blood glucose meters from leading brands like Roche (Accu-Chek Guide, Accu-Chek Instant), Lifescan (OneTouch Verio Flex), and Ascensia (CONTOUR NEXT ONE). Amalgam Rx aims to integrate its 'titration engine' into other diabetes management platforms and EHR systems (e.g., Athena, Epic, Cerner, Allscripts) to streamline provider workflow and bring data back into the EHR.
Compliance Status
FDA 510(k)-cleared as a prescription-only mobile medical application (Class II device, Product Code NDC). Also holds CE Mark for the European region, demonstrating conformity to EU standards for quality management, safety, and performance. Built on a Software as a Medical Device (SaMD) technology platform in conformity with ISO 13485:2016, SOC 2 Type 2, HIPAA, and GDPR requirements.
Pricing Model
No direct-to-consumer model; the company expects to pursue insurance coverage, which may involve a copay for the user.
User Experience
Requires a prescription and an activation code from a healthcare provider. Patients manually enter fasting blood glucose levels daily to receive updated basal insulin dose recommendations. The app provides educational content and supportive messages. Features an updated home page for easier recording and simplified visualization of blood sugar readings and insulin values.
Implementation Complexity
Prescribing healthcare providers must register with the iSage Rx system. An Amalgam Rx representative assists with HCP registration. HCPs select or customize a titration algorithm for each patient. Patients receive a text message to download the app.
Evidence Base
Clinical studies have shown that iSage Rx can improve patients' glucose levels and lead to significant reductions in A1C, with low rates of hypoglycemia. One study showed an average A1C reduction of 1.04% (p=0.002) from baseline, and for those with initial A1C >8%, a reduction of 1.88% (p=0.005). The app is based on clinically validated basal insulin algorithms.
Physician Tip

iSage Rx can significantly streamline basal insulin titration for your Type 2 diabetes patients, reducing the need for frequent office visits for dose adjustments. Customize titration algorithms based on patient-specific needs (e.g., weight, hypoglycemia risk). Leverage the remote monitoring capabilities to keep track of patient progress and adherence. Encourage patients to utilize the in-app educational resources for better self-management. Consider its potential for integration with your EHR to further optimize workflow and data management.

Amalgam Rx is actively working on expanding integrations beyond Bluetooth-enabled glucometers to include CGM and smart insulin pens. Their 'titration engine' is designed for integration into various diabetes operating systems and EHRs (Athena, Epic, Cerner, Allscripts), aiming to provide a seamless flow of patient data and decision support directly within existing clinical workflows. This focus on interoperability suggests a future where insulin titration is a readily available service within broader digital health ecosystems.

Details

Category Endocrinology & Metabolic AI, Patient Engagement & Education, Pharmacology & Dosing AI
Pricing Not available publicly; pursues insurance coverage model. Not a direct-to-consumer model; aims for insurance coverage with a potential copay for users.
DeploymentMobile app (prescription-only), integrated with EHR systems.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

iSage Rx is the first FDA-cleared mobile app for the automated titration of all brands of basal insulin for adults with Type 2 diabetes, aged 21 and older. It received its 510(k) clearance in 2017.

Integrations
EHR Not specified
Specialties Endocrinology, Family Medicine, Internal Medicine

What the Web Says

iSage Rx by Amalgam Rx is an FDA-cleared, prescription-only mobile application designed to help patients with Type 2 diabetes manage their basal insulin dosage. It automates insulin titration based on clinically validated algorithms and provides educational and behavioral support. The app aims to simplify dose management and improve adherence to treatment plans, allowing physicians to monitor progress remotely.

Overall: Positive

Strengths

  • FDA-cleared for automated basal insulin titration in Type 2 diabetes.
  • Compatible with all major basal insulins.
  • Allows physicians to choose and tailor clinically validated algorithms for individual patients.
  • Provides behavioral, clinical, and educational support for patients.
  • Enables remote monitoring of patient's blood sugar levels and adherence by healthcare providers.
  • Simplifies dose management and helps patients reach target blood sugar ranges.

Limitations

  • Requires a prescription and activation code to use.
  • Not intended for patients with Type 1 diabetes, gestational diabetes, or those using an insulin pump.
  • No direct-to-consumer pricing information available; relies on insurance coverage.
  • Not a replacement for professional medical care and management.
  • Limited public reviews from physicians, healthcare IT, or tech reviewers outside of initial launch announcements and company demonstrations.

Based on reviews from: Digital health player Amalgam Rx launches with Type 2 diabetes app - Guided Solutions, iSage Rx - App Store - Apple, Amalgam Rx iSage Insulin App DEMO - DiabetesMine D-Data ExChange Fall 2021, 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY I Background Information: A 510(k) Number K242066 B Applicant Amal - accessdata.fda.gov, iSage Rx: A New Type 2 Dosing App for All Major Basal Insulins - diaTribe.org, Amalgam Rx obtains CE mark for basal insulin titration app - Medical Device Network, iSage Rx - Apps on Google Play, Digital Products | Amalgam Rx

Last updated: 2026-06-23

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate iSage Rx (by Amalgam Rx)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Business Wire
Amalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Medical-Grade AIu2122 Deployment
Amalgam Rx announced a $20 million credit investment from Catalio Capital Management to accelerate the deployment of its Medical-Grade AI solutions, empowering patients and providers in healthcare decision-making. The funding will support market expansion and refinance existing debt, also providing access to Catalio's network of life sciences leaders.
2025-08
Business Wire
Amalgam Rx's Medical-Grade AIu2122 Doubles Digital Health Engagementu2014Validated in Peer-Reviewed Studies
Amalgam Rx announced that its Medical-Grade AIu2122 solutions have doubled digital health engagement, with these findings validated in peer-reviewed studies. This highlights the effectiveness of their AI-powered approach in improving patient interaction and outcomes.
2025-08
UpdateStar
iSage Rx: A Comprehensive Digital Health Solution
This article provides a review of iSage Rx by Amalgam Rx, Inc., highlighting it as a comprehensive digital health solution for medication management and personalized therapy. It emphasizes features like medication synchronization, personalized plans, automated reminders, and drug interaction alerts.
2025-01
Amalgam Rx Newsroom
CVS Health Ventures Makes Strategic Investment in Amalgam Rx
CVS Health Ventures participated in Amalgam Rx's Series B investment round, supporting the scaling of Amalgam's EHR-integrated clinical decision support platform. This investment aims to enhance data-driven, integrated care and improve outcomes for Aetna members through collaboration.
2023-10
Amalgam Rx Newsroom
Amalgam Rxu2122 Enhances Partnership with Novo Nordisku00ae
Amalgam Rx expanded its global agreement with Novo Nordisk for the commercialization of Dose Check, a digital insulin initiation and titration app. The enhanced partnership includes integrating with connected insulin delivery devices, continuous glucose monitors, and EHRs, along with an equity investment from Novo Nordisk.
2022-12
Digital Health News
Amalgam Rx Acquires Clinical Decision Support Company Avhana Health
Amalgam Rx acquired Avhana Health, a clinical decision support (CDS) company with deep integrations into leading electronic health records (EHRs). This acquisition aims to expand Avhana's CDS tools to multiple therapeutic areas and simplify doctors' workflows.
2021-01

Videos

Product demos, reviews, and walkthroughs for iSage Rx (by Amalgam Rx).

View all on YouTube

Frequently Asked Questions

iSage Rx is a digital therapeutic developed by Amalgam Rx designed to help manage insulin titration for patients with diabetes. It provides automated, personalized insulin dosing recommendations, aiming to improve glycemic control and reduce the burden on both patients and physicians in managing complex insulin regimens.
iSage Rx aims to improve compliance through its user-friendly interface and personalized guidance. It provides clear, actionable instructions for insulin adjustments, which can empower patients to take a more active role in their diabetes management and potentially reduce the intimidation associated with insulin titration.
iSage Rx is primarily indicated for patients with diabetes requiring insulin titration. While it can be beneficial for both Type 1 and Type 2 diabetes, specific suitability may depend on individual patient factors, such as cognitive ability, access to technology, and overall health literacy. It's crucial to assess each patient's readiness and appropriateness for a digital therapeutic.
While iSage Rx offers automated recommendations, it's not a substitute for clinical judgment. Limitations may include reliance on accurate patient input and the inability to account for all complex clinical scenarios. Safeguards typically involve requiring physician oversight, regular patient monitoring, and clear instructions for when to contact their healthcare provider.
iSage Rx differentiates itself through its automated, personalized insulin titration algorithms. Compared to manual titration, it aims to provide more consistent and timely adjustments. Clinical studies and real-world data have demonstrated its effectiveness in improving glycemic control and reducing A1C levels.
The pricing model for iSage Rx can vary. It may be offered through direct-to-patient subscriptions, partnerships with healthcare systems, or integrated into broader diabetes management programs. Coverage by insurance can depend on the specific plan and region, and physicians should inquire about reimbursement pathways.
iSage Rx collects patient data related to blood glucose readings, insulin doses, and other relevant metabolic parameters to inform its titration recommendations. Data privacy and security are paramount, with measures typically including encryption, secure data storage, and adherence to HIPAA or other relevant data protection regulations.

Related Tools

Virta Health
Virta Health
Endocrinology & Metabolic AI
Virta Health offers a virtual health program focused on reversing Type 2 diabetes, prediabetes, and obesity through a nutrition-first approach, continuous remote care, and personalized coaching.
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.
UpDoc Inc.
UpDoc Inc.
Clinical Decision Support & Reference
UpDoc is an FDA-cleared, enterprise-ready agentic clinical AI platform that integrates with EHRs to deploy AI agents for continuous, physician-governed care-related tasks, especially for chronic disease management.
GlucoSense
GlucoSense
Endocrinology & Metabolic AI
GlucoSense is an AI-powered CGM intelligence platform that provides personalized insights for individuals with diabetes and tools for population health management for healthcare providers and health plans. It integrates with various CGMs and wearables to offer real-time monitoring, AI-driven food logging, and simplified care team workflows.
Endobits
Bio-Conscious Technologies Inc.
Clinical Decision Support & Reference
Endobits is an automated decision-support platform for diabetes and metabolic health that collects real-time data from various devices, EMRs, and EHRs to triage patients and prioritize those needing intervention.
StackAI for Endocrinology Practices
StackAI
Documentation & Scribing
StackAI helps endocrinology practices deploy secure AI agents that automate patient support, summarize clinical context, and streamline document-driven workflows with enterprise governance and HIPAA-ready controls.

See all Endocrinology & Metabolic AI tools →

Suggest an Edit → | Last Verified: 2026-06-23 | First Added: 2026-06-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.